Capital Change Notice

17 December 2019

Issue of ordinary shares

This notice is given under NZX Listing Rule 3.13.1 and relates to the issue of ordinary shares in AFT Pharmaceuticals Limited under the AFT Pharmaceuticals Limited Long Term Incentive Plan.

Section 1: Issuer information

Name of issuer

AFT Pharmaceuticals Limited

NZX ticker code

AFT

Class of financial product

Ordinary shares

ISIN (If unknown, check on NZX website)

NZAFTE0001S4

Currency

NZD

Section 2: Capital change details

Number issued

1,000

Nominal value (if any)

Not applicable

Issue price per security

$2.80

Nature of the payment

Not applicable

Amount paid up (if not in full)

In full

Percentage of total class of Financial Products issued

0.001%

(calculated on the number of Financial Products of the

Class, excluding any Treasury Stock, in existence)

For an issue of Convertible Financial Products or

Not applicable

Options, the principal terms of Conversion

Reason for issue and specific authority for issue

1,000 shares were issued to an

employee exercising options under the

AFT Pharmaceuticals Limited Long

Term Incentive Plan

Total number of Financial Products of the Class after

97,309,019

the issue (excluding Treasury Stock) and the total

number of Financial Products of the Class held as

Treasury Stock after the issue.

Specific authority for the issue, including a reference

Directors' resolution, Listing Rule 4.6

to the rule pursuant to which the issue is made

Terms or details of the issue (for example: restrictions,

The ordinary shares issued rank pari

escrow arrangements)

passu with the existing ordinary shares

Date of issue

16 Dec 2019

AFT Pharmaceuticals Limited, Level 1, 129 Hurstmere Road, Takapuna, Auckland 0622, New Zealand Incorporated in New Zealand ARBN: ARBN 609 017 969 investor.relations@aftpharm.com

Section 3: Authority for this announcement and contact person

Name of person authorised to make this

Malcolm Tubby

announcement

Contact person for this announcement

Malcolm Tubby

Contact phone number

+64 9 488 0232

Contact email address

malcolm@aftpharm.com

Date of release through MAP

17 Dec 2019

AFT Pharmaceuticals Limited, Level 1, 129 Hurstmere Road, Takapuna, Auckland 0622, New Zealand Incorporated in New Zealand ARBN: ARBN 609 017 969 investor.relations@aftpharm.com

Attachments

  • Original document
  • Permalink

Disclaimer

AFT Pharmaceuticals Limited published this content on 17 December 2019 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 16 December 2019 21:00:02 UTC